European Companies Search Engine
Registration · Authorized signatory (ppa): Klaus Jennewein · Managing Director (2) · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb 23 May 2005 German Trade Register Announcements, Germany (18/05/2005)
Overview
Text
Jennewein Biotechnologie GmbH, Bonn (
Unnamed street ??, 53175 Bonn, Germany
). GmbH. Social contract of April 1, 2005. Subject: biotechnical research, development, manufacture and marketing of products, in particular intermediates, additives and laboratory chemicals for the pharmaceutical, chemical, food and cosmetics industries. Share capital: EUR 25,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Managing Director: Dr. Jennewein, Stefan, Ober-Ramstadt, *??.??.????; Jennewein, Amelie, Bonn, *??.??.???? to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party. Overall prokura together with a managing director or another authorized representative: Dr. Jennewein, Klaus, Bonn, *??.??.????. As not registered: The company's announcements are made in the Federal Gazette.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Chr. Hansen HMO GmbH, Rheinbreitbach, Germany.